FED UP with Bleeding Disorders Act of 2026
Summary
HR 8794, the FED UP with Bleeding Disorders Act, is an early-stage bill referred to committee with no authorized funding. It mandates an HHS interagency review and research initiatives for bleeding disorders in underserved populations. No direct revenue impact on publicly traded companies is identifiable from the bill text.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR 8794 is a procedural authorization bill with no appropriated funds—zero direct revenue impact on any public company.
- 2.The bill targets HHS research and awareness initiatives, not procurement or tax incentives that would benefit specific firms.
- 3.Early-stage legislation with limited sponsorship and no companion bill in the Senate; passage probability is low in the 119th Congress.
Market Implications
No market implications. The bill does not affect any publicly traded company's revenue, costs, or competitive position. The healthcare sector is not impacted by this procedural authorization. Investors should focus on bills with authorized funding, direct procurement, or regulatory changes that alter company economics.
Full Analysis
The FED UP with Bleeding Disorders Act of 2026 was introduced on May 13, 2026, and referred to the House Committee on Energy and Commerce. It is in the earliest legislative stage with no hearings or markups scheduled. The bill directs the Secretary of Health and Human Services to conduct an interagency review and establish initiatives focused on bleeding disorders in underserved populations, particularly women. It does not authorize any specific dollar amount for appropriations; any future funding would require a separate appropriations bill. The bill's findings cite economic costs of heavy menstrual bleeding ($1B direct, $12B indirect annually) but do not create a direct funding stream or procurement program. No publicly traded companies are named or directly affected by the bill's provisions. The legislative path requires committee action, House passage, Senate passage, and presidential signature—a multi-year process with low probability in the current session. The bill's sponsors include a junior House member (Rep. Julie Johnson, D-TX) with only two cosponsors, indicating limited bipartisan momentum. Without authorized funding or a regulatory mandate targeting specific industries, the market impact is negligible.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
ALABAMA MEDICAID AGENCY: $6.3B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
DISTRICT OF COLUMBIA, GOVERNMENT OF: $2.9B Department of Health and Human Services Grant
HEALTH & HUMAN SVC COMMN TX: $1.3B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →